Year To Quarter End Consolidated Statement Of Income

DAIKEN MEDICAL CO.,LTD - Filing #7359163

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
7,406,231,000 JPY
6,896,291,000 JPY
Cost of sales
4,328,671,000 JPY
4,055,632,000 JPY
Gross profit (loss)
3,077,559,000 JPY
2,840,658,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
1,840,124,000 JPY
1,870,906,000 JPY
Operating profit (loss)
1,237,435,000 JPY
969,752,000 JPY
Non-operating income
Interest income
0 JPY
0 JPY
Non-operating income
9,256,000 JPY
2,073,000 JPY
Non-operating expenses
Interest expenses
3,617,000 JPY
2,920,000 JPY
Non-operating expenses
3,705,000 JPY
2,920,000 JPY
Ordinary profit (loss)
1,242,986,000 JPY
968,905,000 JPY
Extraordinary losses
Extraordinary losses
5,141,000 JPY
50,000 JPY
Profit (loss) before income taxes
1,237,844,000 JPY
968,855,000 JPY
Income taxes
349,689,000 JPY
280,729,000 JPY
Profit (loss)
888,155,000 JPY
688,126,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.